1. Introduction {#sec1}
===============

Nowadays, the analytical instrumentations can provide a high resolution separation and low detection limits, down to picograms or below; the whole progressive analytical process can be wasted if an unsuitable sample preparation method has been employed. Thus, sample preparation is of crucial importance for the analysis of drugs in biological samples. The role of sample preparation is to remove interferences and analyte preconcentration, converting the analytes to suitable form for separation and detection. If an unsuitable sample preparation method has been employed before the injection, the whole analytical process may be wasted. Because of the low concentration levels of drug in plasma and the variety of the metabolites, the selected extraction technique should be virtually exhaustive. In recent years, solid phase microextraction (SPME) has been used by many researchers ever since it emerged in the early 1990s \[[@B1]\]. SPME technique has been widely used in many different areas such as environmental analysis \[[@B2]\], food analysis \[[@B3]\], bioanalysis \[[@B4]\], drug monitoring \[[@B5]\], and toxicology \[[@B6]\]. SPME can be used as direct immersion of the fiber into the sample to extract the analytes, or introduction of the fiber in the sample headspace to extract volatile compounds that are partitioned between gaseous and liquid phases. Many factors, such as pH, temperature, salt concentration, and stirring, affect the equilibrium constant and equilibration time \[[@B7]--[@B16]\].

Another microextraction related technique is stir-bar sorptive extraction (SBSE) which is an extraction technique for enrichment of volatile and semivolatile organic compounds having high extraction efficiency compared to SPME but has longer extraction time. The technique has been applied effectively in environmental analysis mainly with gas chromatography-mass spectrometry (GC-MS). In addition, the SBSE technique was applied to some drugs in biological samples in combination with GC-MS \[[@B112]\].

Recent development in solid phase microextraction related techniques is microextraction by packed sorbent (MEPS). MEPS is the miniaturization of conventional SPE and can be connected online to GC or LC without any modifications \[[@B132]--[@B161]\]. The extraction steps in MEPS are the same as in standard SPE---extraction, loading, washing, and elution---and these have to be optimized to obtain the highest analyte recovery. In MEPS, solvent and sample volumes are significantly reduced compared to SPE. The MEPS technique has been used to extract a wide range of drugs and metabolites in biological fluids such as urine, plasma, and blood \[[@B161]\].

This review presents recent developments of sample preparation in drug bioanalysis of complex fluids using SPME, SBSE, and MEPS.

2. Solid Phase Microextraction (SPME) for Drug Analysis {#sec2}
=======================================================

In SPME, the extraction is based on the partitioning of the analyte between the organic phase on the fused silica fibre and the matrix. Many factors, such as pH, temperature, salt concentration, and stirring, affect the equilibrium constant and the equilibration time \[[@B1]\]. Fibre lifetime is a significant issue. SPME fibre is quite sensitive to complex matrix such as plasma. In addition, type of polymer, temperature, duration, and additives coming from the sample solution influence the stability of the coating. It should be noted that additives such as sodium hydroxide and salt could catalyse polymer thermal degradation. In some bioanalytical studies, fibre life-time was decreased to about 20 samplings instead of 80 \[[@B8], [@B9]\]. In the two past decades, SPME as a sample preparation method for drug analysis has been used with various analysis methods. SPME was used with different separation techniques such as capillary gas chromatography (CGC) \[[@B18]--[@B25]\], GC/GC-MS \[[@B26]--[@B32]\], LC/LC-MS \[[@B33]--[@B45]\], GC-ICP-MS \[[@B46]--[@B52]\], and HPLC-UV/HPLC-MS \[[@B53]--[@B63]\].

2.1. Fiber and Monolithic In-Tube SPME {#sec2.1}
--------------------------------------

In tube solid phase microextraction (in-tube SPME) is a new format of SPME that can be coupled online to LC for automated analysis of less volatile and polar compounds like drug metabolites. This technique was used for the determination of drugs and metabolites in different biological matrices like urine, plasma and cell culture media from in vitro assays \[[@B64]--[@B66]\]. In addition fiber in-tube SPME online with capillary electrophoresis (CE) was used for the analysis of amitriptyline, imipramine, nortriptyline, and desipramine in human urine samples \[[@B67]\]. In this work, two types of Zylon fiber were used. One is high modulus (HM) with heat treatment and the other is regular (AS) without heat treatment after spinning the fibers. In addition, DB-5 capillary of 10 mm length was packed with a fiber with the same length. In order to investigate the effect of the fiber and the capillary coating on extraction efficiency, various kinds of extraction media were prepared as follows: HM fiber packed in a DB-5 capillary, HM/DB-5; AS fiber packed in a DB-5 capillary, AS/DB-5; HM fiber packed in an uncoated fused-silica capillary, HM/FS; and only DB-5 capillary, DB-5. For the evaluation of the effect of the packing density on the extraction efficiency, 26% and 52% packed capillaries were prepared. The packing density has been calculated by using the average diameter of the fibers as 11.5 *μ*m. The former was packed with 123 filaments and the latter with 246 filaments in a 10 mm DB-5 capillary \[[@B67]\]. This method was then applied to the analysis of amitriptyline in human urine and the results showed that the hyphenated system would be a powerful tool for the analysis of analytes in biological matrices, DB-5 capillary was cut to 10 mm length and the fiber of the same length was packed into this capillary. In order to investigate the effect of the fiber and the capillary coating on extraction efficiency, various kinds of extraction media were prepared as follows: HM fiber packed in a DB-5 capillary, HM/DB-5; AS fiber packed in a DB-5 capillary, AS/DB-5; HM fiber packed in an uncoated fused-silica capillary, HM/FS; and only DB-5 capillary, DB-5. For the evaluation of the effect of the packing density on the extraction efficiency, 26 and 52% packed capillaries were prepared. The packing density has been calculated by using the average diameter of the fibers as 11.5 *μ*m. The former was packed with 123 filaments and the latter with 246 filaments in a 10 mm DB-5 capillary. The density is based on the volume ratio between the space and the filled part of the inner capillary in which the fibers were packed. The running buffer was composed of 20 mM Na2HPO4 buffer (pH 9.3), 0.6 mM-cyclodextrin, and 20% acetonitrile.

Monolith in-tube SPME is another approach for drug analysis in complex matrix. Different strategies were developed for preparation of monolithic in tube SPME ([Figure 1](#fig1){ref-type="fig"}). A hybrid organic-inorganic silica monolith with ceyanoethyl functional groups was synthesized by hydrolysis and polycondensation of precursors via a two-step catalytic sol-gel process that was used as a sorbent for in-tube SPME \[[@B68], [@B69]\]. Briefly, fused-silica capillaries (I.D. 250 *μ*m) were activated with 1 M NaOH and then 1 M HCl. After rinsing with double distilled water, they were dried at 160°C under N~2~ flow for 5 h. The hybrid monolith was synthesized by hydrolysis and polycondensation of precursors via a two-step catalytic sol-gel process. The optimal preparation conditions were as follows: 180 *μ*L of methanol, 25 *μ*L of 2 M acetic acid, 110 *μ*L off CN-TEOS, and 110 *μ*L of TEOS were mixed in a 1.5 mL Eppendorf vial. After thorough vortexing, the mixture was left for hydrolysis at 60°C for 5 h. After cooling to room temperature, 10 mg of N-dodecylamine was added to the solution. Then the pretreated capillary was filled to a certain length with the sol by a syringe. The capillary was sealed at both ends with silicone rubber and then was allowed to further react at 40°C for 15 h. Subsequently, the capillary was rinsed with ethanol to remove the N-dodecylamine and soluble hydrolysis products and then dried at 60°C for 48 h. The total and effective lengths of the hybrid silica monolith were 20 and 15 cm, respectively \[[@B69]\].

As it is shown in [Figure 1](#fig1){ref-type="fig"}, four capillaries are connected in the modified cross connector to build the online fiber-in-tube SPME-CE system. To minimize the band broadening effects, the gap between the separation capillaries must be strictly decreased. Therefore, the capillaries between the two buffer reservoirs were connected using a microscope until the gap between the capillaries was less than 10 *μ*m. In addition, the SEM picture ([Figure 1](#fig1){ref-type="fig"}) showed that the monolith is attached tightly to the inner-wall of the capillary. The flow-through pores size distribution determined by mercury porosimeter was around 4 m with a narrow size distribution, which results in high permeability and favourable mass transfer in extraction applications.

In another work, a restricted access material (RAM) was employed for preparation of a lab-made biocompatible in-tube SPME capillary that enables the direct injection of biological fluids as well as the simultaneous exclusion of macromolecules by chemical diffusion barrier and drug preconcentration \[[@B70], [@B71]\]. In this work, silica particles (C18--45 *μ*m) were slurried in methanol and packed into 50 mm (length) of polyether ether ketone (PEEK) tubing (I.D. 0.02 inch) and then the capillary column was capped at both ends by a 1/16 in. (1 in. = 2.54 cm) zero-volume union fitted with a 10 *μ*m frit. After this procedure, the capillary was conditioned with phosphate buffer (0.05 mol L^−1^, pH 6.0) at a flow-rate of 1.0 mL min^−1^ for 20 min. Initially, 50 mL phosphate buffer solution (0.05 mol L^−1^, pH 6.0) was percolated through the capillary at a flow rate of 1.0 mL min^−1^, followed by 25 mL Bovine serum albumin solution 1.0 mg mL^−1^ (prepared in phosphate buffer solution) and by 25 mL glutaraldehyde solution (25%, v/v). After 5 h, the columns were washed with 10 mL sodium borohydride solution (1.0 mg mL^−1^) and then with 60 mL water. The RAM-BSA column was stored in phosphate buffer solution (0.05 mol L^−1^, pH 7.4) at 4°C. The schematic structure of RAM is shown in [Figure 2](#fig2){ref-type="fig"}.

In addition, monolithic molecular imprinted polymer (MIP) fiber based solid phase microextraction (SPME) was developed for selective and sensitive determination of different drugs and biomarkers in biological samples \[[@B72], [@B73]\]. In situ polymerization of silica capillary mold using E as template was reported and in some studies the MIP fibers are preparedand each fiber could be used for about 50 extraction-cycles without any significant decrease in extraction capacity. [Figure 3](#fig3){ref-type="fig"} illustrated the MIP strategy for preparation of MIP in tube SPME fiber.

Other types of monolithic in tube SPME were prepared by different kinds of monomer and cross-linker mixtures, such as poly(acrylamide-ethylene glycol dimethacrylate). Poly(AA-EGDMA) monolith was selected as sorbent for SPME of three protoberberine alkaloids ([Figure 4](#fig4){ref-type="fig"}). Briefly, AA was weighed and put in a 1 mL screw capped glass vial, followed by adding isooctane, toluene, and methanol as porogen. After AA was completely dissolved, the cross-linker EGDMA and the initiator AIBN were added to the above solution. Ultrasonication was applied for 20 min to remove dissolved oxygen. Finally, the prepolymerization solution was introduced into the modified PEEK tube carefully, and then the PEEK tube was sealed and put into a water bath for polymerization (60°C, 3 h). After polymerization, the monolith was washed with acetonitrile to remove porogen and unreacted reagents \[[@B74]\], poly(meta acrylic acid-ethylene glycol) \[[@B75]--[@B77]\], and poly(4-vinylpyridine-co-ethylene dimethacrylate) \[[@B78]\]. Also, in-tube SPME/LC method was developed and validated for rifampicin interferon *α* ~2a~ determination in plasma samples for therapeutic drug monitoring and in plasma samples and lidocaine and its Metabolite MEGX in plasma samples \[[@B79]--[@B81]\].

In summary, monolithic in-tube SPME was shown to be an appropriate method for drug metabolism studies and routine analysis or pharmacokinetics as the parent compound and main metabolites could be monitored in various matrices of interest.

2.2. Headspace Solid-Phase Microextraction (HS-SPME) in Drug Bioanalysis {#sec2.2}
------------------------------------------------------------------------

HS-SPME, an alternative sample extraction technique, allows concentrating volatile and semivolatile analytes from the headspace above the sample on a coated fiber and to transfer the analytes from the fiber directly into the injector port of a GC without further manipulations \[[@B82]\]. [Table 1](#tab1){ref-type="table"} shows the different drugs and pharmaceutical components determined by HS-PME method.

A schematic structure of HS-PME is shown in [Figure 5](#fig5){ref-type="fig"} \[[@B84]\]. In some works commercial fibers were used. In addition, the sol-gel method was used for fiber preparation in HS-PME technique. In the following part, we will describe different kinds of precursors that were used in HSPME method.

2.3. Sol-Gel HS-SPME {#sec2.3}
--------------------

The sol-gel process provides a useful method of preparing organic-inorganic hybrid materials through the hydrolysis and condensation of suitable metal alkoxides, particularly, silicone alkoxide, which readily allows forming three-dimensional (3D) network under relatively mild conditions \[[@B99]\].

[Table 2](#tab2){ref-type="table"} lists the names and chemical structures of the principal ingredients of the coating solution used. The sol-gel process may involve mainly several parts as follows: (1) ring-opening polymerization between KH-560 and DM-*β*-CD; (2) hydrolysis and polycondensation among the product of (1), TEOS, and OH-TSO to generate a 3D network; (3) chemical anchoring of the polymeric networks to the outer surface of the fused-silica fiber; (4) deactivating residual silanol groups on the stationary phase with PMHS, aimed to reduce harmful adsorptive effects. Thus, a surface-bonded polymeric coating DM-*β*-CD/OH-TSO is formed as schematically represented in [Figure 6](#fig6){ref-type="fig"} \[[@B88]\].

2.4. Molecularly Imprinted Polymers Solid Phase Microextraction (MIPs-SPME) {#sec2.4}
---------------------------------------------------------------------------

Molecularly imprinted polymers (MIPs) have proven to be useful materials in analytical chemistry. MIPs are cross-linked synthetic polymers obtained by copolymerizing a monomer with a cross-linker in the presence of a template molecule. After polymerization, the template is removed from the porous network by washing, leaving cavities in the polymeric matrix that are complementary in size, shape, and chemical functionality to the template. Thus, the imprinted polymer is able to rebind selectively the analyte (the template) under certain experimental conditions \[[@B100]\].

Accordingly, the combination of molecular imprinting and SPME would ideally provide a powerful analytical tool with the characteristics of both technologies, simplicity, flexibility, and selectivity. There are two strategies in this field; the easiest way for combining both technologies was proposed by mullet \[[@B101]\], which consisted of packing a capillary with the MIP particles for in-tube SPME and was used for the selective determination of propranolol in serum samples. The developed method was successfully applied and the advantages of in-tube SPME were obvious (high enrichment factors provided by multiple draw/eject cycles, ease of automation, and fast operation). However, this methodology is not free of some important drawbacks such as the lack of compatibility between the solvent needed to desorb analytes from the MIP and the mobile phase used (typical drawback of online MISPE protocols) and the necessity of extra instrumentation (pump, multiport valves). Thus, the preparation of silica fibers coated with a MIP to perform SPME would be the best option and different works have been developed in this field \[[@B100]\]. Figures [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"} show schematic setup of these two strategies.

Most papers that have been developed in MIP-SPME field are about fiber preparation for separation of different valuable targets of complex media such as Clenbuterol and Structural Analogues \[[@B102]\], triazines \[[@B103]\], diacetylmorphine and analogous compounds \[[@B104]\], Prometryn \[[@B105]\], bisphenol A \[[@B106], [@B107]\], anabolic steroids \[[@B108]\], 2,2′-bipyridine \[[@B109]\], antibiotic drugs \[[@B110]\], and sulfamethazine \[[@B111]\].

### 2.4.1. Preparation of MIP-Coated Fibers (MIP-CF) {#sec2.4.1}

SPME conditions based on the MIP-coated fibers are valuable methods that developed in recent years. As simple approach for preparation of bisphenol A (BPA) MIP-coated SPME fibers a capillary was inserted into a larger bore capillary to form a sleeve as mold \[[@B106]\]. The prepolymer solution, which comprised BPA, acrylamide (AM), 3-(trimethoxysilyl) propyl methacrylate (TRIM), AIBN, and ACN, was introduced into the interspace between the two capillaries, followed by polymerization under UV photoirradiation ([Figure 9](#fig9){ref-type="fig"}). The larger bore capillary was etched away with hydrofluoric acid after the polymerization. This approach showed that this very simple method could become a routine preparation procedure for MIP-coated fibers. The MIP coating on the silica fibers was homogeneous and porous and showed good mechanical and chemical stability. According to the result as of this work, it was demonstrated that the MIP-coated fibers had better adsorption/desorption kinetics compared with the monolith MIP fiber. Under the optimized SPME conditions, selective extraction of BPA from standard mixture aqueous sample was feasible with the MIP-coated fibers.

3. Stir-Bar Sorptive Extraction (SBSE) {#sec3}
======================================

Since SBSE was developed in 1999 \[[@B112]\], it has already shown significance among the sorptive extraction techniques. SBSE and SPME are microextraction techniques with low, or even no, consumption of organic solvents. The analytes are extracted from the matrix into the polymer coating immobilized on a glass tube with a magnetic core. Rapid molecular-recognition equilibrium between adsorption and desorption can be established, since sampling is performed simultaneously with the stirring. As a result, competitive sorption from an additional stirrer (e.g., magnet essential for the SPME technique) can also be avoided \[[@B113]\].

The main differences between the two techniques are the design of the extraction system and the amount of the sorbent material. The sorbent materials are similar, although till today the availability of commercial SBSE materials is rather limited \[[@B114]\]. Contrary to SPME, quantitative recoveries are often achievable with SBSE due to the clearly higher sample capacity. SBSE can also be employed for the extraction of relatively polar compounds. Quantitative extraction can be achieved for solutes with log *K* ~o/w~ values of ca. 4, and reasonable efficiencies are obtained for solutes with log *K* ~o/w~ values above 3 \[[@B115]\] For highly polar compounds, similar approaches as for SPME can be applied (i.e., derivatisation). Same as SPME in SBSE various parameters such as type and thickness of the coating, extraction time, sample properties (pH, ionic strength), agitation, temperature, and analyte desorption could be evaluated. The extraction time is typically longer than in SPME, because the amount of coating is greater and it takes longer to reach equilibrium. The analyte desorption is more critical for SBSE than for SPME, likewise due to the greater amount of coating. A high flow rate of gas (up to 100 mL min^−1^) is recommended for fast desorption of analytes during thermal desorption \[[@B115]\].

3.1. Sol-Gel Technology in Stir-Bar Sorptive Extraction {#sec3.1}
-------------------------------------------------------

For the first time, Liu et al. \[[@B116]\] used sol-gel technology in stir-bars to produce a partially hydroxyterminated-PDMS coated stir-bar, which was used for extracting a group of PAHs and organophosphorous compounds.

The sol-gel process offers a convenient, versatile pathway for preparing advanced inorganic and organic-inorganic hybrid material systems, with tunable porosity, selectivity, and thermal and chemical stability. The schematic of sol-gel reactions is shown in [Figure 10](#fig10){ref-type="fig"} (where methyltrimethoxysilane (MTMOS) and hydroxy-terminated polydimethylsiloxane (PDMS) are shown to represent sol-gel precursor and sol-gel active organic polymer, resp.) \[[@B117]\].

Despite its numerous advantages over conventional SPME fibers, SBSE also suffers from serious limitations \[[@B117]\] as follows:limited number of commercially-available coatings;coating is not chemically bonded to the substrate leading to the possibility of bleeding at even relatively low temperature during thermal desorption and transfer of the extracted analytes from the stir-bar to the GC system;coating is vulnerable to washing away if proper solvent is not used during solvent desorption;thermal desorption requires an expensive thermal desorption unit;thick, highly viscous polymeric sorbents used on the stir-bar require hours to reach the extraction equilibrium;there is a need for a relatively high volume of back extraction solvent, which evidently dilutes the preconcentrated analytes.

High porous sol-gel PDMS coated stir-bar with 30 *μ*m coating thickness was developed by Liu et al. \[[@B116]\]. The coating was found thermally stable up to 300°C. The sol-gel PDMS coated stir-bars were tested for the extraction of *n*-alkanes, PAHs, and organ phosphorus pesticides. The sol-gel PDMS coated stir-bar reached extraction equilibrium in less than 15 min. In addition, unlike commercial PDMS coated stir-bars, the sol-gel PDMS coated stir-bar is equally suitable for both polar and nonpolar analytes.

Different sorbents for SBSE sol-gel method were developed in recent years. A sol-gel PDMS/PVA coated stir-bar for the extraction of organophosphorus pesticides (OPPs) in honey samples was used \[[@B119]\]. The extracted analytes were back-extracted by solvent desorption. The back-extraction solvent, which contained the analyte(s) of interest, was then injected into the GC using large volume injection, followed by GC-FPD. The extraction performance of sol-gel CW/PDMS/PVA was compared with commercial PDMS stir-bar and Carboxen/PDMS SPME fiber using headspace extraction. Sol-gel CW/PDMS/PVA coated stir-bar demonstrated the highest sorption capacity and \~10 times higher sensitivity \[[@B120]\]. Also, a sol-gel PDMS/*β*-CD coating (30--150 *μ*m) for the extraction of polar compounds from different matrices (e.g., estrogens in environmental water and bisphenol A in drinking water) \[[@B121]\]. The same sol-gel sorbent (sol-gel PDMS/*β*-CD) was utilized for extracting brominated flame retardants from soil and dust samples employing ultrasound-assisted extraction followed by HPLC analysis \[[@B122]\]. SBSE performances were compared for four different sol-gel coatings including PDMS/b-CD, PDMS, CW/PDMS/PVA, and PDMS/PVA. The sol-gel PDMS/*β*-CD coated stir-bar was found to be the most efficient for the target compounds. In addition to superior extraction performance, sol-gel PDMS/*β*-CD coated stir-bars demonstrated excellent durability, and no discernible loss of extraction efficiency was observed even after 100 extraction cycles.

3.2. Molecularly-Imprinted Stir-Bar Sorptive Extraction (MI-SBSE) {#sec3.2}
-----------------------------------------------------------------

MI-SBSE is based on the partitioning of target analytes between a liquid sample and a stationary phase-coated stir-bar. Until now, only polydimethylsiloxane (PDMS) coated stir-bars are commercially available, restricting the range of applications to the extraction of hydrophobic compounds (organochlorine and organophosphorus pesticides) due to the polar character of PDMS. Besides, the MIP-coated stir-bars showed not only the expected high selectivity but also rapid equilibrium adsorption, thanks to the porous nature of the imprinted polymer obtained combined with a suitable thickness of coated polymer film (*μ*160--180 lm) \[[@B123]\]. More recently, the use of MIP-coated stir-bars prepared by chemical bonding of the MIP to the stir-bar through silylation of the substrate surface and then multiple copolymerization reaction was proposed for the determination of various components in different samples \[[@B124]--[@B128]\]. The schematic diagrams of the preparation of MIP-SBSE coating using terbuthylazine as template molecule is shown in [Figure 11](#fig11){ref-type="fig"} \[[@B125]\].

3.3. Stir-Bars Sorptive Extraction Based on Monolithic Material (SBSEM) and Molecularly Imprinted Polymer Monolith Microextraction (MIPMME) {#sec3.3}
-------------------------------------------------------------------------------------------------------------------------------------------

The preparation of monolithic materials is very simple just by polymerization of a monomer mixture with a porogen solvent, forming a porous polymer. In this way, Huang and Yuan developed monolithic material obtained by in situ copolymerization of octyl methacrylate and ethylene dimethacrylate in the presence of a porogen solvent containing 1-propanol, 1,4-butanediol, and water with azobisisobutyronitrile as the initiator \[[@B129]\]. The results demonstrate that prepared stir-bar was suitable for preconcentration of both apolar and polar analytes. The enrichment factors for phenanthrene, anthracene, and pyrene were 150, 134, and 189, respectively. The SBSEM shows good batch-to-batch reproducibility and good stability and can be reused at least 10 times for the extraction of polycyclic aromatic hydrocarbons in seawater ([Figure 12](#fig12){ref-type="fig"}).

In another in situ copolymerization approach, vinylpyrrolidone and divinylbenzene in the presence of a porogen solvent containing cyclohexanol and 1-dodecanol with azobisisobutyronitrile as initiator were used for SBSEM preparation \[[@B130]\]. Polycyclic aromatic hydrocarbons were used to investigate the extraction efficiencies of SBSEM for apolar analytes. Hormones, aromatic amines, and phenols were selected as test analytes to investigate the extraction efficiencies of SBSEM for weakly and strongly polar compounds. The results showed that the new SBSEM could enrich the above-mentioned organic compounds effectively. It is worthy to mention that the SBSEM can enrich some heavy metal ions, such as Cu^2+^, Pb^2+^, Cr^3+^, and Cd^2+^, through coordination adsorption.

In another case, poly(vinylpyridine-ethylene dimethacrylate) is used as SBSEM combined with high performance liquid chromatography with diode array detection under the optimized experimental conditions for analysis of target compounds in wastewater samples \[[@B131]\]. The method showed good linearity and repeatability, as well as advantages such as sensitivity, simplicity, low cost, and high feasibility.

4. Microextraction by Packed Sorbent (MEPS) {#sec4}
===========================================

MEPS was recently introduced as a novel method for sample preparation, being a miniaturization of the conventional SPE technique, in which the sample volume, extraction, and washing solvents volumes are greatly reduced compared to SPE. MEPS differs from commercial SPE in that the packing is integrated directly into the syringe and not into a separate column. Moreover, the packed syringe can be used several times, more than 100 times using plasma or urine samples, whereas a conventional SPE column is used only once. MEPS can handle small sample volumes (10 *μ*L plasma, urine, or water) as well as large volumes (1000 *μ*L).

The extraction steps in MEPS are the same as in standard SPE extraction, washing, and elution and these have to be optimized to obtain the highest analyte recovery. In MEPS extraction procedures, additional steps for postcleaning and reconditioning have to be included to enable multiple uses of the MEPS sorbent. Blood samples require dilution of 20--25 times with water or acidic water, while 4-5 times dilution is needed for plasma samples. Using mixed-mode (anion-cation exchange), the sample pH has to be adjusted to produce charged analytes. MEPS was used with real samples from clinical institutions or pharmaceutical industry for established drugs and new drug candidature ([Figure 13](#fig13){ref-type="fig"}).

The superior performance of MEPS was recently illustrated by online LC-MS and GC-MS assays of drugs and metabolites in water, urine, plasma, and blood samples \[[@B132]--[@B161], [@B136]--[@B170]\]. The combination of MEPS and liquid chromatography mass spectrometry (LC-MS) is a good tool for the screening and determination of drugs and metabolites in blood, plasma, and urine samples. Mass spectrometry is presently one of the most powerful detection techniques, particularly in pharmaceutical analysis, where good selectivity and high sensitivity are often needed. MEPS significantly reduces the volume of solvent and sample needed. This approach to sample preparation is very promising for many reasons: (1) it is easy to use, (2) it is a fully automated online procedure, (3) it is rapid, and (4) the cost of analysis is minimal compared to conventional solid-phase extraction.

4.1. MEPS Extraction Procedures {#sec4.1}
-------------------------------

Plasma samples were diluted four times while blood samples diluted 20 times with water.

*(i) Conditioning Step.* The sorbent was conditioned with 150 *μ*L methanol and subsequently with 150 *μ*L water.

*(ii) Sample Loading Step.* Sample can be loaded by multiple aspirates-dispenses cycles (5 × 100 *μ*L).

*(iii) Washing Step.* The sorbent was washed after sample loading by 150 *μ*L water.

*(iv) Elution of the Analytes.* Elution solution was organic solvent (≥60%).

The MEPS technique has been used to extract a wide range of analytes in different matrices (urine, plasma, and blood). Hence, several drugs such as local anesthetics and their metabolites, the anticancer drugs roscovitine, olomoucine, busulphan, cyclophosphamide, and AZD3409, the *β*-blockers acebutolol and metoprolol, the neurotransmitters dopamine and serotonin, methadone, and cocaine and cocaine metabolites have been extracted from biological samples such as blood, plasma, or urine samples using MEPS \[[@B132]--[@B161], [@B136]--[@B170]\]. [Table 3](#tab3){ref-type="table"} shows the application of MEPS technique in different matrices and various types of drug.

4.2. Molecularly Imprinted Polymer as Sorbent in MEPS {#sec4.2}
-----------------------------------------------------

Molecularly imprinted polymer was used as extracting sorbent in MEPS for the simultaneous determination of four local anaesthetics (ropivacaine, lidovacaine, bupivacaine, and mepivacaine) in human plasma and urine samples have been evaluated. In comparison with protein precipitation, MIP-MEPS offer enrichment of analytes and elimination of interferences from matrix constituents. This may be important for increasing sensitivity and for robustness of the LC-MS system. Ion suppression was observed in protein precipitation method for lidocaine, ropivacaine, and mepivacaine. The matrix effect was more pronounced using protein precipitation. The matrix effect (ME) for these substances ranged from 50% to 146% using protein precipitation while it was less than 20% using MIP-MEPS. This suggests that cleaner extracted samples can be obtained with MEPS and that matrix related problems can be reduced \[[@B163]\]. In comparison with conventional SPE, the MEPS method can handle smaller sample volumes (10--100 *μ*L). This is mainly an advantage for samples from children.

4.3. Extraction of Proteins from Plasma by MEPS {#sec4.3}
-----------------------------------------------

MEPS technique online with LC-MS/MS was used for the quantification of SNSR receptors agonist peptide BAM8-22 and antagonist BAM22-8 in plasma samples \[[@B165]\]. MEPS-C8 was used and spiked plasma sample (125 *μ*L) was diluted (1 : 1) with 0.1% CHOOH in water; 50 *μ*L were drawn onto the MEPS-syringe three times. The sorbent was then washed once with 50 *μ*L of 5% methanol in water to remove other interferences. The analytes were then eluted by 40 *μ*L 0.25% ammonium hydroxide in methanol-water 95 : 5 (v/v) directly into LC injector. The calibration curve in plasma was in the range of 20.0--3045 nmol/L. The regression correlation coefficients for plasma samples were ≥0.99. The between-batch accuracy and precision for BAM8-22 ranged from −13 to −2.0% and 4.0 to 14%, respectively. Additionally, the accuracy and precision for BAM22-8 ranged from −13 to 7.0% and from 3.0 to 12%, respectively. The method was used for pharmacokinetic studies for BAMs in plasma samples \[[@B165]\]. MEPS technique provided significant advantages such as the speed and the simplicity of the sample-preparation process. Compared with other extraction techniques, such as protein precipitation and ultrafiltration, MEPS gave cleaner samples and higher recovery (\>90%). The method had good accuracy and good precision within the studied calibration range. Furthermore, the method reduced the sample preparation time for BAMs (less than one minute per sample), which is of great importance to handle unstable analytes such as BAMs in plasma and blood samples. The method was applied to plasma samples from preclinical studies \[[@B165]\]. The potential savings in handling time reduced solvent use. The simplicity of MEPS technique will continue to attract interest among analytical chemists searching for improved analysis methods.

In summary, the significant advantages of MEPS are reduction in the amount of sorbent bed, solvents, and sample preparation times and reduction in carry-over effects.

5. Monolithic Packed 96-Tips for High Throughput Bioanalysis {#sec5}
============================================================

Recently we introduced a 96-tips set packed with a plug of a monolithic adsorbent. Using such a set, it is possible to handle a 96-well plate in only 2 minutes \[[@B171]\]. Packed 96-tips sample preparation is a clean, highthroughput, and automated sample-preparation method. Samples are prepared in a 96-well plate format and the analytes adsorb onto the polymer-based monoliths in the extraction step. The next step purifies the sample by washing the sorbent with an appropriate washing solution. In a final step, the analytes were directly eluted into a 96-well plate using an appropriate solvent for the analytes and the subsequent instrumental analysis.

5.1. Preparation of Monolithic Plug in Tips {#sec5.1}
-------------------------------------------

The polymerization mixture of methacrylate monoliths consists of a solution containing glycidyl methacrylate (20%), ethylene glycol dimethacrylate (15.5%), butyl methacrylate (3.5%), AIBN (1 wt% with respect to monomers), and 1-dodecanol (30%) and cyclohexanol (30%) was vortexed for 10 min and purged with nitrogen for 10 min in order to remove oxygen. The pipette tips were filled with about 8 mm (6-7 *μ*L) by the capillary action and placed vertically inside the polymerization apparatus. The polymerization using UV light at 254 nm was allowed to proceed first for 60 min with the sharp end of the tip down and at a distance to the lamp of 15 cm and then for 25 min with the sharp end up and at a distance of 5 cm to the lamp. After completion of polymerization, the tips were removed, inspected under microscope for bubbles, and washed with acetone to remove the porogenic solvents and other compounds remaining in the monolith ([Figure 14](#fig14){ref-type="fig"}).

The key aspect of the monolithic phase is that monolithic material can offer both good binding capacity and low back-pressure properties compared to, for example, silica phases. Using this device, a 96-well plate could be handled in 2--4 minutes.

5.2. Monolithic Packed 96-Tips Application in Bioanalysis {#sec5.2}
---------------------------------------------------------

Evaluation of monolithic packed 96-tips for the extraction of drugs \[[@B171]--[@B176]\] such as anticancer drugs (busulphan, cyclophosphamide, roscovitine), *β*-blocker drugs (metoprolol, pindolol), and local anesthetics (lidocaine, ropivacaine, bupivacaine) from human plasma or blood samples has been developed and validated ([Table 4](#tab4){ref-type="table"}). Utilizing plasma samples, the tips could be used several times (5 times) and still get good results. Utilizing blood samples, packed tips could only be used once. The results showed that the method is selective and accurate. It was shown that small sample volumes can be handled, solvent consumption was low, and the procedure was very fast (2 min per 96-well plate) ([Table 4](#tab4){ref-type="table"}). Application of monolithic methacrylate polymer packed 96-tips in bioanalysis.

6. Conclusions {#sec6}
==============

The advantages of various kinds of SPME, SBSE, and MEPS as powerful sample preparation methods in bioanalysis have been demonstrated and illustrated in many cases. It is clear that the number of the papers published in this research area has increased during the last decade. In addition, the results showed the ability of these techniques for determination of drugs in biological samples. Future work should be focused on finding of more selective, high throughput adsorption capacity and stable sorbents with capability for extraction of large molecules.
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![Construction of automated in-tube SPME-HPLC/MS system and Scanning electron microscope images of the cross section of the hybrid silica monolith: wide view (b) and close-up view (c) \[[@B69]\].](JAMC2014-921350.001){#fig1}

![Scheme of the operation mode of the six-port switching valve in the RAM in-tube SPME developed method \[[@B71]\].](JAMC2014-921350.002){#fig2}

![Schematic illustration of MIP preparation procedure \[[@B73]\].](JAMC2014-921350.003){#fig3}

![Schematic of (a) the formation of polydopamine layer and (b) modification of PEEK tube and preparation of poly(AA-EGDMA) monolith and Scanning electron micrograph of (A) polydopamine layer on the inner wall of PEEK tube, (B) poly(AA-EGDMA) monolith, and (C) interface of inner wall of PEEK tube and polymer monolith \[[@B74]\].](JAMC2014-921350.004){#fig4}

![SPME high-temperature headspace sampling \[[@B84]\].](JAMC2014-921350.005){#fig5}

![The chemical structure of the DM-*β*-CD/OH-TSO coating \[[@B29]\].](JAMC2014-921350.006){#fig6}

![Preparation of molecularly imprinted fiber \[[@B100]\].](JAMC2014-921350.007){#fig7}

![Schematic representation of in-tube MIP SPME configuration. (a) Load position (extraction); (b) injection position (desorption) \[[@B101]\].](JAMC2014-921350.008){#fig8}

![The preparation process of BPA-imprinted MIP coating on the silylated wall of the silica capillaries. Schematic representation of BPA-imprinted MIP coating on the silylated wall of the silica capillaries and Scanning electron micrographs of MIP coating of the fiber. (a) ×200, (b) ×20000 \[[@B106]\].](JAMC2014-921350.009){#fig9}

![Chemical reactions involved in the synthesis of surface-bonded sol-gel hybrid organic-inorganic polymeric network \[[@B117]\].](JAMC2014-921350.010){#fig10}

![Schematic diagrams of the preparation of MIP-SBSE coating using terbuthylazine as template molecule and Scanning electron micrographs of the surface structure of the MIP- and NIP-coated stir-bar. (a) and (c) are the NIP coating for magnitude of 100 and 5000, respectively, (b) and (d) are the MIP coating for magnitude of 100 and 5000, respectively \[[@B125]\].](JAMC2014-921350.011){#fig11}

![Photograph of different dimensions of SBSEM \[[@B129]\].](JAMC2014-921350.012){#fig12}

![MEPS syringe with sorbent.](JAMC2014-921350.013){#fig13}

![Monolithic packed 96-tips.](JAMC2014-921350.014){#fig14}

###### 

HSPME for analysis of different drug components.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Drug                                                                                                                                                                 Disease                                                  Fiber type                                                                                                                                                                                                                                                                   Sample matrix                  Analytical method   Reference
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ ------------------- ------------
  Dichlorobenzene                                                                                                                                                      Damage to the liver and the kidneys                      Polydimethylsiloxane                                                                                                                                                                                                                                                         Human blood                    GC/MS               \[[@B83]\]

  Illegal drugs (acetylated amphetamine, secobarbital, phenobarbital, methadone, propoxyphene, imipramine, acetylated codeine, flunitrazepam, diacetylated morphine)   Polyacrylate                                             (In situ) derivatisation\                                                                                                                                                                                                                                                    Urine/serum                    GC/MS               \[[@B84]\]
                                                                                                                                                                                                                                (acetylation or silylation)                                                                                                                                                                                                                                                                                                     

  Thymol                                                                                                                                                               Food/pharmaceuticals                                     Polydimethylsiloxane-\                                                                                                                                                                                                                                                       Human plasma                   GC/MS               \[[@B85]\]
                                                                                                                                                                                                                                divinylbenzene crimped fiber                                                                                                                                                                                                                                                                                                    

  Amphetamine-related drugs                                                                                                                                            Abused drugs                                             Polydimethylsiloxane                                                                                                                                                                                                                                                         Human urine                    GC/MS               \[[@B86]\]

  Rivastigmine                                                                                                                                                         Symptomatic treatment of\                                Polydimethylsiloxane/divinylbenzene\                                                                                                                                                                                                                                         Canine plasma                  GC/MS               \[[@B87]\]
                                                                                                                                                                       mild to moderate dementia                                (pdms/dvb) or polydimethylsiloxane\                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                (pdms)                                                                                                                                                                                                                                                                                                                          

  Menthol                                                                                                                                                              Flavouring agent                                         65 µm polydimethylsiloxane/divinylbenzene (PDMS/DVB)-coated fibers                                                                                                                                                                                                           Plasma/urine of rats           GC/MS               \[[@B88]\]

  Ephedrine, methamphetamine                                                                                                                                           Anaesthesia\                                             Sol-gel                                                                                                                                                                                                                                                                      Human urine                    GC                  \[[@B29]\]
                                                                                                                                                                       psychoactive drug                                                                                                                                                                                                                                                                                                                                                                        

  Asarones                                                                                                                                                             Antiepileptic drugs                                      Polydimethylsiloxane (PDMS), 65 *μ*mm polydimethylsiloxane/divinylbenzene (PDMS/DVB), 65 *μ*mm carbowax/divinylbenzene (CW/DVB), 75 *μ*mm carboxen poly(dimethylsiloxane) (CAR/PDMS),\                                                                                       Plasma                         GC/MS               \[[@B89]\]
                                                                                                                                                                                                                                85 *μ*mm polyacrylate (PA),                                                                                                                                                                                                                                                                                                     

  Paeonol                                                                                                                                                              Eczema                                                   100 µm polydimethylsiloxane (PDMS), 65 *μ*m polydimethylsiloxane/divinylbenzene (PDMS-DVB), 65 *μ*m carbowax/divinylbenzene (CW-DVB), 75 *μ*m carboxen poly(dimethylsiloxane) (CAR-PDMS), and 85 *μ*m polyacrylate (PA) were purchased from Supelco (Bellefonte, PA, USA).   Rabbit plasma /essential oil   GC/MS               \[[@B90]\]

  Fentanyl                                                                                                                                                             Surgical analgesia and sedation                          Sol-gel technology                                                                                                                                                                                                                                                           Human plasma                   GC/MS               \[[@B91]\]

  Diisopropylfluorophosphate                                                                                                                                           Miotic agent in treatment of chronic glaucoma            65 mm polydimethylsiloxane/divinylbenzene\                                                                                                                                                                                                                                   Rat plasma/brain tissue        GC/MS               \[[@B92]\]
                                                                                                                                                                                                                                (pdms/dvb)                                                                                                                                                                                                                                                                                                                      

  Some phenothiazine derivatives                                                                                                                                       Antipsychotics\                                          100 *μ*m PDMS, 85 *μ*m polyacrylate, 65 *μ*m\                                                                                                                                                                                                                                Human blood                    GC/NPD              \[[@B93]\]
                                                                                                                                                                       (major tranquilizers),\                                  PDMS/divinylbenzene (DVB), 65 *μ*m Carbowax (CW)/DVB, 85 *μ*m stableflex carboxen (CAR)/PDMS, and 50/30 *μ*m stableflex DVB/CAR/PDMS                                                                                                                                                                                            
                                                                                                                                                                       antiparkinsonism drugs, antihistaminics                                                                                                                                                                                                                                                                                                                                                  

  Methadone                                                                                                                                                            Analgesic                                                Nanostructured a-carboxy\                                                                                                                                                                                                                                                    Plasma/urine                   GC/FID              \[[@B94]\]
                                                                                                                                                                                                                                Polypyrrole (ppy-*α*-COOH)                                                                                                                                                                                                                                                                                                      

  Ethyl glucuronide                                                                                                                                                    Promising biomarker of heavy prenatal alcohol exposure   100 *μ*m polydimethylsiloxane\                                                                                                                                                                                                                                               Human placenta                 GC/MS               \[[@B95]\]
                                                                                                                                                                                                                                red and black fibers                                                                                                                                                                                                                                                                                                            

  Ranitidine                                                                                                                                                           Prescribed                                               Carboxen/polydimethylsiloxane                                                                                                                                                                                                                                                Solid state                    GC/MS               \[[@B96]\]

  Volatile organic metabolites                                                                                                                                         volatile organic metabolites                             Pdms, pdms/dvb, cw/dvb,\                                                                                                                                                                                                                                                     Mentha ×piperita L             GC/qMS              \[[@B97]\]
                                                                                                                                                                                                                                Pa, car/pdms, and dvb/car/pdms                                                                                                                                                                                                                                                                                                  

  *E. coli* BL21                                                                                                                                                       Antimicrobial agents                                     For example, 100 *μ*m PDMS, 65 *μ*m\                                                                                                                                                                                                                                         Cell metabolism                GC/MS               \[[@B98]\]
                                                                                                                                                                                                                                DVB/PDMS, 75 *μ*m CAR/PDMS,\                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                and 50/30 *μ*m CAR/PDMS/DVB                                                                                                                                                                                                                                                                                                     
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Function and chemical structures of the coating solution ingredients for sol-gel-derived DM-*β*-CD/OH-TSO coating \[[@B29]\].

  --
  --

###### 

Extraction of different analytes by MEPS technique.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Components                                                                          Sample matrix        MEPS sorbent                                                                         References
  ----------------------------------------------------------------------------------- -------------------- ------------------------------------------------------------------------------------ ----------------------
  Methadone                                                                           Human urine          Silica-C8                                                                            \[[@B133]\]

  Dopamine/serotonin                                                                  Human urine          Silica-C8                                                                            \[[@B134]\]

  Cocaine/metabolites                                                                 Human urine          Silica-C8                                                                            \[[@B135]\]

  Clozapine/metabolites                                                               Dried blood spots    Silica-C8                                                                            \[[@B136]\]

  Methadone/buprenorphine/norbuprenorphine/naloxone\                                  Plasma               Silica-C8                                                                            \[[@B137]\]
  /levosulpiride                                                                                                                                                                                

  Pravastatin/pravastatin lactone                                                     Rat plasma/urine     Silica-C8                                                                            \[[@B138]\]

  Immunosuppressive drugs (Cyclosporine, everolimus,\                                 Whole blood          Silica-C8                                                                            \[[@B139]\]
  Sirolimus, tacrolimus)                                                                                                                                                                        

  Oxcarbazepine/metabolites                                                           Plasma/saliva        Silica-C18                                                                           \[[@B140]\]

  Antiepileptic drugs                                                                 Human plasma/urine   Silica-C18                                                                           \[[@B141]\]

  Amiodarone/desethylamiodarone                                                       Human plasma         Silica-C18                                                                           \[[@B142]\]

  Methadone                                                                           Dried blood spots    Silica-C18                                                                           \[[@B143]\]

  Biogenic amines                                                                     Human urine          Silica-C18                                                                           \[[@B144]\]

  Metabolites of monoterpenes                                                         Human urine          C18/silica phases                                                                    \[[@B145]\]

  Acebutolol, metoprolol                                                              Human plasma/urine   Polystyrene polymer                                                                  \[[@B146]\]

  Busulphan                                                                           Human plasma         Polystyrene polymer                                                                  \[[@B147]\]

  Linezolid and amoxicillin                                                           Human plasma         (C2, C8, C18, M1 (80% C8 and 20% SCX), and Sil (pure silicate))                      \[[@B148]\]

  Cotinine                                                                            Human urine          (C2, C8, C18, silica, and C8/SCX)                                                    \[[@B149]\]

  Psychotropic drugs                                                                  Human serum          C18, C8, and C8-SCX                                                                  \[[@B150]\]

  Antipsychotic drugs                                                                 Human plasma         80% C8 and 20% SCX                                                                   \[[@B151]\]

  Local anaesthetics                                                                  Human plasma         Benzenesulphonic acid cation exchange silica                                         \[[@B152]\]

  Ropivacaine /metabolites                                                            Human urine          Polystyrene polymer, ISOLUTE ENV+                                                    \[[@B153]\]

  Lidocaine, glycylxylidide (GX), monothylglycylxylidide (MEGX), and 3-OH lidocaine   Human plasma/urine   Silica based (C8), polymer based (ENV+), and a methacrylate based organic monolith   \[[@B154]\]

  Antidepressants                                                                     Human plasma         C8/strong cationic exchange                                                          \[[@B155]\]

  Ropivacaine                                                                         Human plasma         Methylcyanopropyl/silarylene (50/50)                                                 \[[@B156]\]

  Ropivacaine, lidocaine, bupivacaine, mepivacaine                                    Human plasma         Molecularly imprinted polymers (mips)                                                \[[@B157], [@B163]\]

  Cyclophosphamide                                                                    Human plasma         C2-sorbent                                                                           \[[@B158]\]

  Codeine metabolites                                                                 Human urine          Barrel insert needle (BIN), poly(styrene co-divinylbenzene)\                         \[[@B159]\]
                                                                                                           (PS DVB)                                                                             

  Propranolol, metoprolol, verapamil                                                  Human urine          C2, C8, C18, M1 (cation exchanger), and Sil (pure silica)                            \[[@B160]\]

  Bam peptide                                                                         Human plasma         C8                                                                                   \[[@B165]\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Applications of monolithic methacrylate polymer packed 96-tip.

  Compound class/compound   Sample matrix   Sample volume (*μ*L)   Analytical method   Calibration range   References
  ------------------------- --------------- ---------------------- ------------------- ------------------- ----------------------
  Local anaesthetics                                                                                        
   Lidocaine                Human plasma    100                    LC-MS/MS            14--5000 nM         \[[@B171]\]
   Ropivacaine              Human plasma    100                    LC-MS/MS            2--2000 nM          \[[@B172]\]
   Bupivacaine              Human plasma    100                    LC-MS/MS            2--2000 nM          \[[@B173]\]
  Anticancer drugs                                                                                          
   Cyclophosphamide         Mice blood      20                     LC-MS/MS            10--2000 nM         \[[@B176]\]
   Busulphan                Human blood     100                    LC-MS               5--2000 nM          \[[@B176]\]
   Roscovitine              Human plasma    100                    LC-MS/MS            14--5000 nM         \[[@B171]\]
  *β*-Blockers                                                                                              
   Pindolol                 Human plasma    100                    LC-MS/MS            0.5--5000 nM        \[[@B174], [@B175]\]
   Metoprolol               Human plasma    100                    LC-MS/MS            0.5--5000 nM        \[[@B174], [@B175]\]
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